4.535

6.05% -0.255

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $4.535, with a volume of 135.63K. It is down -6.05% in the last 24 hours and up +4.65% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Previous Close:

$4.79

Open:

$4.74

24h Volume:

135.63K

Relative Volume:

0.19

Market Cap:

$295.26M

Revenue:

$207.32M

Net Income/Loss:

$-61.04M

P/E Ratio:

-4.7353

EPS:

-0.9577

Net Cash Flow:

$-25.97M

1W Performance:

-3.64%

1M Performance:

+4.65%

6M Performance:

+145.90%

1Y Performance:

-34.69%

1-Day Range:

$4.475

$4.75

1-Week Range:

$4.46

$4.855

52-Week Range:

$1.17

$7.78

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1089)

Industry

Medical Devices (141)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

450

Twitter

Next Earnings Date

2026-08-07

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	4.54	311.52M	207.32M	-61.04M	-25.97M	-0.9577
ABT Abbott Laboratories	109.67	192.51B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	331.73	130.11B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	90.54	116.83B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.48	75.11B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	90.67	52.80B	6.30B	1.07B	1.09B	1.8406

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy
Dec-31-24	Initiated	Lake Street	Buy
Dec-17-24	Resumed	JP Morgan	Neutral
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

04:54 AM

522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC - MarketBeat

04:54 AM

Aug 14, 2026

Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake - Stock Titan

Aug 14, 2026

Aug 12, 2026

Treace Medical Concepts (TMCI) officer disposes shares for tax or exercise costs - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) CEO John T. Treace reports 19.2% beneficial stake - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) CFO uses 37,102 shares to cover equity-related taxes - Stock Titan

Aug 12, 2026

Treace Medical Concepts (TMCI) officer uses 16,253 shares for tax or exercise costs - Stock Titan

Aug 12, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 - simplywall.st

Aug 12, 2026

Aug 11, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts - MarketBeat

Aug 11, 2026

Aug 10, 2026

Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial - MarketBeat

Aug 10, 2026

Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating - marketscreener.com

Aug 10, 2026

Aug 09, 2026

Treace Medical Concepts (TMCI) Stock Jumps As Cash Burn Eases But Sales Stall - Sahm

Aug 09, 2026

Aug 08, 2026

Treace Medical Concepts: Q2 Earnings Snapshot - theheraldreview.com

Aug 08, 2026

Aug 07, 2026

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Aug 07, 2026

Form 8K Treace Medical Concepts Inc For: 7 August By Investing.com - Investing.com Nigeria

Aug 07, 2026

Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 07, 2026